Independent Portfolio Consultants’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $35K | Sell |
1,065
-260
| -20% | -$8.55K | 0.01% | 559 |
|
|
2017
Q1 | $43K | Sell |
1,325
-288
| -18% | -$9.35K | 0.01% | 584 |
|
|
2016
Q4 | $58K | Sell |
1,613
-52
| -3% | -$1.87K | 0.02% | 530 |
|
|
2016
Q3 | $77K | Sell |
1,665
-215
| -11% | -$9.94K | 0.02% | 482 |
|
|
2016
Q2 | $94K | Sell |
1,880
-100
| -5% | -$5K | 0.03% | 456 |
|
|
2016
Q1 | $106K | Sell |
1,980
-710
| -26% | -$38K | 0.03% | 463 |
|
|
2015
Q4 | $177K | Sell |
2,690
-10
| -0.4% | -$658 | 0.05% | 349 |
|
|
2015
Q3 | $152K | Sell |
2,700
-65
| -2% | -$3.66K | 0.03% | 390 |
|
|
2015
Q2 | $163K | Sell |
2,765
-68
| -2% | -$4.01K | 0.03% | 403 |
|
|
2015
Q1 | $176K | Sell |
2,833
-197
| -7% | -$12.2K | 0.04% | 389 |
|
|
2014
Q4 | $174K | Sell |
3,030
-3,940
| -57% | -$226K | 0.04% | 399 |
|
|
2014
Q3 | $375K | Sell |
6,970
-325
| -4% | -$17.5K | 0.1% | 336 |
|
|
2014
Q2 | $382K | Sell |
7,295
-540
| -7% | -$28.3K | 0.11% | 330 |
|
|
2014
Q1 | $414K | Sell |
7,835
-2,190
| -22% | -$116K | 0.13% | 295 |
|
|
2013
Q4 | $402K | Sell |
10,025
-6,530
| -39% | -$262K | 0.14% | 306 |
|
|
2013
Q3 | $625K | Sell |
16,555
-8,455
| -34% | -$319K | 0.25% | 134 |
|
|
2013
Q2 | $980K | Buy |
+25,010
| New | +$980K | 0.44% | 38 |
|